1. Home
  2. MSM vs CRSP Comparison

MSM vs CRSP Comparison

Compare MSM & CRSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MSC Industrial Direct Company Inc.

MSM

MSC Industrial Direct Company Inc.

HOLD

Current Price

$116.74

Market Cap

6.0B

Sector

Industrials

ML Signal

HOLD

Logo CRISPR Therapeutics AG

CRSP

CRISPR Therapeutics AG

HOLD

Current Price

$51.85

Market Cap

4.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MSM
CRSP
Founded
1941
2013
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.0B
4.9B
IPO Year
1996
2016

Fundamental Metrics

Financial Performance
Metric
MSM
CRSP
Price
$116.74
$51.85
Analyst Decision
Hold
Buy
Analyst Count
6
17
Target Price
$96.20
$70.29
AVG Volume (30 Days)
633.9K
1.6M
Earning Date
04-01-2026
05-11-2026
Dividend Yield
3.45%
N/A
EPS Growth
N/A
N/A
EPS
1.69
N/A
Revenue
$3,363,817,000.00
$289,590,000.00
Revenue This Year
$5.82
$807.72
Revenue Next Year
$5.26
$172.52
P/E Ratio
$68.15
N/A
Revenue Growth
4.99
9169.85
52 Week Low
$78.80
$39.81
52 Week High
$115.97
$78.48

Technical Indicators

Market Signals
Indicator
MSM
CRSP
Relative Strength Index (RSI) 76.70 48.55
Support Level $82.51 $50.33
Resistance Level N/A $60.29
Average True Range (ATR) 3.10 2.27
MACD 0.66 0.24
Stochastic Oscillator 96.82 46.61

Price Performance

Historical Comparison
MSM
CRSP

About MSM MSC Industrial Direct Company Inc.

Founded in 1941, MSC Industrial Direct originally manufactured and sold cutting tools to metalworking shops in New York. Through a series of acquisitions and organic expansions, MSC has grown into an industrial distribution powerhouse with a focus on specialized metalworking products and services. The firm also distributes a wide breadth of maintenance, repair, and operations supplies. MSC primarily operates in North America, where it derives over 95% of its revenue.

About CRSP CRISPR Therapeutics AG

Crispr Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for clustered regularly interspaced short palindromic repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. The company is focused on using this technology to treat genetically defined diseases. Crispr's first approved drug is Casgevy, which was developed in collaboration with Vertex Pharmaceuticals and targets sickle-cell disease and transfusion-dependent beta-thalassemia. The company is advancing a variety of gene editing programs in immuno-oncology, cardiovascular, and a stem cell-derived therapy to treat Type 1 diabetes.

Share on Social Networks: